Scalper1 News
Animal-health company Zoetis (ZTS) early Tuesday beat analysts’ Q4 estimates but guided 2014 below consensus, sending shares down in early trading Tuesday. Zoetis said sales rose 7% over the year-earlier quarter to $1.25 billion, vs. analyst consensus of $1.21 billion. Adjusted net income was 36 cents a share, beating estimates by 2 cents. The company did not offer a year-ago comparison for the latter, likely because it was then still part of Scalper1 News
Scalper1 News